Robert Vrancken

Title: Robert Vrancken: Innovator in Antiviral Compounds

Introduction

Robert Vrancken is a notable inventor based in Berchem, Belgium. He has made significant contributions to the field of antiviral compounds, particularly through his innovative research and development efforts. His work focuses on creating effective solutions for preventing and treating infections caused by pestivirus in animals.

Latest Patents

Robert Vrancken holds a patent for "Pyrrolopyridine and imidazopyridine antiviral compounds." This invention relates to a compound of formula (I) or a stereoisomer, or tautomer, (I) wherein A, A, R, and R have specific meanings as defined in the claims and description. The patent also encompasses compositions, particularly pharmaceuticals, that include such compounds, along with their uses for the prevention and/or treatment of pestivirus infections in animals. He has 1 patent to his name.

Career Highlights

Robert Vrancken is affiliated with Katholieke Universiteit Leuven, where he engages in research that bridges the gap between academia and practical applications in the pharmaceutical industry. His work is characterized by a commitment to advancing antiviral therapies and improving animal health.

Collaborations

Throughout his career, Robert has collaborated with talented individuals such as Eleonora Kiss and Nesya Goris. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in the field.

Conclusion

Robert Vrancken's contributions to antiviral compounds exemplify the impact of dedicated research and innovation in addressing critical health challenges. His work continues to inspire advancements in the pharmaceutical industry.